Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men -: Proposal of reference values for defining lipodystrophy

被引:77
作者
Bonnet, E
Delpierre, C
Sommet, A
Marion-Latard, F
Hervé, R
Aquilina, C
Labau, E
Obadia, M
Marchou, B
Massip, R
Perret, B
Bernard, J
机构
[1] Hop Purpan, Unit Infect & Trop Dis, F-31059 Toulouse, France
[2] Hop Purpan, INSERM, U 563, F-31059 Toulouse, France
[3] Hop Rangueil, Rheumatol Unit, Toulouse, France
[4] Grave Hosp, Unit Dermatol, Toulouse, France
[5] INSERM, U558, Unit Epidemiol & Publ Hlth, Toulouse, France
关键词
HIV; lipodystrophy; DXA; fat mass ratio; antiretroviral drugs; bone mineral density;
D O I
10.1385/JCD:8:3:287
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to define standard values for fat mass distribution by dual-energy X-ray absorptiometry in human immunodeficiency virus (HIV)-negative men and to analyze factors associated with lipodystrophy in HIV-infected men. Total-body composition was analyzed in 241 HIV-negative men (controls) and 162 HIV-infected men. We created a fat mass ratio (FMR) as the ratio of the percentage of the trunk fat mass to the percentage of the lower limbs fat mass. We defined the FMR standard values as the mean value +/- standard deviation. We compared body mass index (BMI), fat mass percentage (%FM), lean mass (LM), bone mineral density (BMD), and FMR between the control group and HIV-infected men, by age range, according to prescription of treatment and presence of clinical lipodystrophy. The FMR standard value is equal to 1.3 +/- 0.2. The FMR was higher in treated HIV-infected men with or without clinical lipodystrophy. The FMR was similar for naive HIV-infected men and controls. It was positively correlated with age, cumulative time on treatment, zidovudine, stavudine, or indinavir. BMD and fat mass were lower for treated and naYve HIV-infected men than for HIV-negative men. The FMR seems to be a valuable index for measuring fat mass distribution. We defined FMR standard values from the largest group of HIV-negative men to our knowledge. Applying FMR to HIV patients could help physicians to diagnose lipodystrophy earlier.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 35 条
  • [11] GRAHAM NM, 2000, J ACQUIR IMMUNE D S1, V25, P4
  • [12] Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
    Hadigan, C
    Meigs, JB
    Corcoran, C
    Rietschel, P
    Piecuch, S
    Basgoz, N
    Davis, B
    Sax, P
    Stanley, T
    Wilson, PWF
    D'Agostino, RB
    Grinspoon, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) : 130 - 139
  • [13] BODY-COMPOSITION OF HUMANS - COMPARISON OF 2 IMPROVED 4-COMPARTMENT MODELS THAT DIFFER IN EXPENSE, TECHNICAL COMPLEXITY, AND RADIATION EXPOSURE
    HEYMSFIELD, SB
    LICHTMAN, S
    BAUMGARTNER, RN
    WANG, J
    KAMEN, Y
    ALIPRANTIS, A
    PIERSON, RN
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 52 (01) : 52 - 58
  • [14] BONE-MINERAL NORMATIVE DATA IN MALMO, SWEDEN - COMPARISON WITH REFERENCE DATA AND HIP FRACTURE INCIDENCE IN OTHER ETHNIC-GROUPS
    KARLSSON, MK
    GARDSELL, P
    JOHNELL, O
    NILSSON, BE
    AKESSON, K
    OBRANT, KJ
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 1993, 64 (02): : 168 - 172
  • [15] Osteopenia in HIV-infected patients:: is it the disease or is it the treatment?
    Knobel, H
    Guelar, A
    Vallecillo, G
    Nogués, X
    Díez, A
    [J]. AIDS, 2001, 15 (06) : 807 - 808
  • [16] Bone and mineral metabolism in human immunodeficiency virus infection
    Kühne, CA
    Heufelder, AE
    Hofbauer, LC
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) : 2 - 9
  • [17] Lipodystrophy in patients naive to HIV protease inhibitors
    Madge, S
    Kinloch-de-Loes, S
    Mercey, D
    Johnson, MA
    Weller, IVD
    [J]. AIDS, 1999, 13 (06) : 735 - 737
  • [18] Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
    Mallal, SA
    John, M
    Moore, CB
    James, IR
    McKinnon, EJ
    [J]. AIDS, 2000, 14 (10) : 1309 - 1316
  • [19] Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors:: a prospective cohort study
    Martinez, E
    Mocroft, A
    García-Viejo, MA
    Pérez-Cuevas, JB
    Blanco, JL
    Mallolas, J
    Bianchi, L
    Conget, I
    Blanch, J
    Phillips, A
    Gatell, JM
    [J]. LANCET, 2001, 357 (9256) : 592 - 598
  • [20] Massip P, 1997, THERAPIE, V52, P615